1. Home
  2. TAYD vs PLX Comparison

TAYD vs PLX Comparison

Compare TAYD & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$58.84

Market Cap

165.2M

Sector

Industrials

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

BUY

Current Price

$2.73

Market Cap

182.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TAYD
PLX
Founded
1955
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
165.2M
182.9M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
TAYD
PLX
Price
$58.84
$2.73
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.3K
★ 701.9K
Earning Date
10-02-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
0.14
★ 0.27
Revenue
$41,649,673.00
★ $52,744,000.00
Revenue This Year
$40.70
$55.77
Revenue Next Year
$13.65
N/A
P/E Ratio
$418.36
★ $10.04
Revenue Growth
N/A
★ N/A
52 Week Low
$40.50
$1.60
52 Week High
$90.37
$3.19

Technical Indicators

Market Signals
Indicator
TAYD
PLX
Relative Strength Index (RSI) 48.96 55.26
Support Level $57.54 $2.59
Resistance Level $62.30 $2.75
Average True Range (ATR) 2.42 0.09
MACD -0.43 -0.01
Stochastic Oscillator 46.10 50.10

Price Performance

Historical Comparison
TAYD
PLX

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: